Pathobiology of liver fibrosis: a translational success story
about
Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver MyofibroblastsConnexins and pannexins in liver damageModulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cellsStem/Progenitor Cell Niches Involved in Hepatic and Biliary RegenerationNovel Molecular Mechanisms in the Development of Non-Alcoholic SteatohepatitisNitric oxide in liver fibrosis: The role of inducible nitric oxide synthaseLiver pathology of hepatitis C, beyond grading and staging of the diseaseCytoglobin as a Marker of Hepatic Stellate Cell-derived MyofibroblastsMolecular prognostic prediction in liver cirrhosisReversibility of liver fibrosisAntifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney FibrosisNuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?Evaluation of liver fibrosis: "Something old, something new…"Promising therapies for treatment of nonalcoholic steatohepatitis.Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes.The spleen in liver cirrhosis: revisiting an old enemy with novel targets.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis.20S-Protopanaxadiol, an aglycosylated ginsenoside metabolite, induces hepatic stellate cell apoptosis through liver kinase B1-AMP-activated protein kinase activation.Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontinHepatitis C virus-induced hepatocellular carcinomaContinuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept StudyHistologic Assessment of Intratumoral Lymphoplasmacytic Infiltration Is Useful in Predicting Prognosis of Patients with Hepatocellular Carcinoma.HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells.Changes of the Cytoplasmic Proteome in Response to Alcoholic Hepatotoxicity in Rats.Liver fibrosis: Review of current imaging and MRI quantification techniques.Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.Surgical Management of Chronic Pancreatitis.Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.Transcriptional control of cardiac fibroblast plasticity.The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulationHepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways.Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosisInvolvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells.Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.
P2860
Q26745566-128217AC-53BE-4426-82A1-C4EEBA8B982EQ26750050-E51302EB-241D-4063-829E-F244351A2DD1Q26753022-D6DB608D-9EFF-4A52-90C3-AC50077A9F48Q26765898-72D65966-7D63-47B6-806D-E1C4D5A471FCQ26766533-197A3CAD-2781-487D-8636-19B192E85B93Q26771779-500F03CA-FF47-4664-9B28-3EF229921162Q26773294-C7D59FF8-7A88-439F-8711-ED64CD006087Q26776162-EDAB8581-F56E-4717-BCA3-3347D6EAA2D6Q26784251-8112C318-CB1D-41E8-92BD-830CA275C1F6Q26822053-BACE673E-DBDF-44ED-9B1D-273561AE60BBQ27336127-F3D6634F-CF35-4A13-8918-0AA066571A02Q28066233-71D7EE91-4BDC-4039-A88C-0C3FDD514760Q28068532-6AEC62D1-E78B-49C9-89A5-19DD58898AC3Q30248578-29238E4A-8000-4301-9C2E-1D015C030796Q30250322-B0960E67-6A32-4184-B734-840551FE41BFQ30355782-E71D1CF5-BA5D-4BAB-BF77-34AB8B280E96Q31171499-8842A903-0E8A-407E-A8AA-D424AD77E8C9Q33574413-75CE7CDE-4856-4810-80C4-E2A97EEA812BQ33579420-F200C7A6-1B8E-44C7-8C2B-1BCA3E638040Q33605760-8C2F709B-B860-4189-BEB1-2FDCF3CB44D3Q33826344-51FC64A8-D712-47AD-BAC0-291EDB3A662FQ33850019-9C69E9D3-4D8C-44F7-B7CD-DD1648970D4DQ33877800-9080E987-848C-4D3A-965C-7E80C467B71EQ35824057-87D43A82-2D28-42D8-8C15-F4FDE556738CQ35903372-7E33F961-EF88-43AA-9D55-40C8CB5ED6F0Q36022359-149AAF21-9860-48C7-8B4C-A0192455876CQ36065064-2EF76EB3-2A92-4DA4-A009-13120CAB920DQ36088607-9DB3AD2B-FA62-4837-B4C0-4F7F5CC1BE05Q36226373-CCA5A9F5-DE8E-4FF8-8939-F2342C320200Q36259454-1B172B84-C6D0-4E1E-94C8-B96CDBA1EAB3Q36279532-08D3982F-B8AB-4A9A-B130-1311F4439C64Q36400091-7D1B8451-52E6-46E4-A8D7-AA4328A36546Q36588292-5B3EEAF2-5E2A-4975-9F82-096C1CA6757DQ36609712-6BBCBE6B-3BA1-4454-A306-3AD36A0E3700Q36783013-23FF9B87-F935-4508-8B78-D1994FC518C7Q36947366-C6A6321D-599C-429D-8EA3-4F929BEB85BFQ37112309-1839075E-126B-4FB8-8384-A1ADD6648A4AQ37164508-F007EC5E-BCEF-4558-998C-9B7EFA415647Q37431827-E7AB7154-E2A2-4337-924A-6CE667902BB6Q37544826-45507BA4-E0F6-46D0-88D9-30955F7F3AB7
P2860
Pathobiology of liver fibrosis: a translational success story
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pathobiology of liver fibrosis: a translational success story
@ast
Pathobiology of liver fibrosis: a translational success story
@en
Pathobiology of liver fibrosis: a translational success story
@nl
type
label
Pathobiology of liver fibrosis: a translational success story
@ast
Pathobiology of liver fibrosis: a translational success story
@en
Pathobiology of liver fibrosis: a translational success story
@nl
prefLabel
Pathobiology of liver fibrosis: a translational success story
@ast
Pathobiology of liver fibrosis: a translational success story
@en
Pathobiology of liver fibrosis: a translational success story
@nl
P2093
P2860
P1433
P1476
Pathobiology of liver fibrosis: a translational success story
@en
P2093
Michael C Wallace
Scott L Friedman
Youngmin A Lee
P2860
P304
P356
10.1136/GUTJNL-2014-306842
P407
P577
2015-02-13T00:00:00Z